Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
US Federal Trade Commission (FTC): Amgen’s patent application acquisition deal is under antitrust review.

US Federal Trade Commission (FTC): Amgen’s patent application acquisition deal is under antitrust review.

智通财经智通财经2026/08/21 15:56
Show original
The US Federal Trade Commission (FTC): Amgen's patent application acquisition deal is under antitrust review.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!